ZEB1 and neoplasm: Thus, in summary, in this study we have shown that miR-449a could be considered as a tumor suppressive miRNA in ER + tumors, and that miR-200c, which targets ZEB1 and ZEB2 (major regulators of EMT) can reverse EMT in our cell line pII an ER-acquired resistance cell line.